The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Russell E. Lewis

(713) 795-8326

[email]@uh.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • (713) 795-8326. 2011
  • University of Houston College of Pharmacy, Texas Medical Center Campus, 1441 Moursund Street, Unit 424, USA. 2002 - 2010
  • Department of Clinical Sciences and Administration, University of Houston College of Pharmacy, Houston, USA. 2009
  • College of Pharmacy, University of Houston and The Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, TX, United States. 2007

References

  1. Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosis. Lewis, R.E., Leventakos, K., Liao, G., Kontoyiannis, D.P. Antimicrob. Agents Chemother. (2011) [Pubmed]
  2. Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis. Lewis, R.E., Albert, N.D., Liao, G., Hou, J., Prince, R.A., Kontoyiannis, D.P. Antimicrob. Agents Chemother. (2010) [Pubmed]
  3. Overview of the changing epidemiology of candidemia. Lewis, R.E. Curr. Med. Res. Opin (2009) [Pubmed]
  4. Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis. Lewis, R.E., Albert, N.D., Kontoyiannis, D.P. Antimicrob. Agents Chemother. (2008) [Pubmed]
  5. Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis. Lewis, R.E., Albert, N.D., Kontoyiannis, D.P. J. Antimicrob. Chemother. (2008) [Pubmed]
  6. What is the "therapeutic range" for voriconazole? Lewis, R.E. Clin. Infect. Dis. (2008) [Pubmed]
  7. Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice. Lewis, R.E., Chamilos, G., Prince, R.A., Kontoyiannis, D.P. Antimicrob. Agents Chemother. (2007) [Pubmed]
  8. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis. Lewis, R.E., Liao, G., Hou, J., Chamilos, G., Prince, R.A., Kontoyiannis, D.P. Antimicrob. Agents Chemother. (2007) [Pubmed]
  9. Pharmacodynamic implications for use of antifungal agents. Lewis, R.E. Curr. Opin. Pharmacol (2007) [Pubmed]
  10. In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin. Lewis, R.E., Wiederhold, N.P., Prince, R.A., Kontoyiannis, D.P. J. Antimicrob. Chemother. (2006) [Pubmed]
  11. Decision making in antifungal monotherapy versus combination therapy. Lewis, R.E. Pharmacotherapy (2006) [Pubmed]
  12. Detection of gliotoxin in experimental and human aspergillosis. Lewis, R.E., Wiederhold, N.P., Chi, J., Han, X.Y., Komanduri, K.V., Kontoyiannis, D.P., Prince, R.A. Infect. Immun. (2005) [Pubmed]
  13. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp. Lewis, R.E., Wiederhold, N.P., Klepser, M.E. Antimicrob. Agents Chemother. (2005) [Pubmed]
  14. Frequency and species distribution of gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center. Lewis, R.E., Wiederhold, N.P., Lionakis, M.S., Prince, R.A., Kontoyiannis, D.P. J. Clin. Microbiol. (2005) [Pubmed]
  15. The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy. Wiederhold, N.P., Lewis, R.E. Expert. Opin. Investig. Drugs (2003) [Pubmed]
  16. Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. Lewis, R.E., Diekema, D.J., Messer, S.A., Pfaller, M.A., Klepser, M.E. J. Antimicrob. Chemother. (2002) [Pubmed]
  17. Pharmacotherapy of Candida bloodstream infections: new treatment options, new era. Lewis, R.E. Expert. Opin. Pharmacother (2002) [Pubmed]
  18. Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Lewis, R.E., Kontoyiannis, D.P., Darouiche, R.O., Raad, I.I., Prince, R.A. Antimicrob. Agents Chemother. (2002) [Pubmed]
 
WikiGenes - Universities